rcg2017logo

Red Cell Genotyping 2017: Patient Safety

The 7th Annual Red Cell Genotyping Symposium will be held Wednesday, September 27th in the Lister Hill Auditorium, National Institutes of Health, Bethesda, MD.  Registration is now open!

Program

Scientific Committee
Willy A. Flegel, MD - National Institutes of Health
Disclosure: RHD genotyping royalty recipient and intellectual property right owner

Gregory A. Denomme, PhD,FCSMLS(D) - BloodCenter of Wisconsin
Disclosures: Grifols SA - Honorarium; Quotient Biosciences - Honorarium; Ortho Clinical Diagnostics - Honorarium 

Activity Director
Jerome L. Gottschall, MD - BloodCenter of Wisconsin
No relationship to disclose

Symposium Coordinators
Karen Byrne, MS, MT(ASCP)SBB - NIH Clinical Center
Sue Johnson, MSTM, MT(ASCP)SBB - BloodCenter of Wisconsin 
Carrie Kapczynski  - BloodCenter of Wisconsin
Coordinators are not involved with content

Scheduled Speakers

 Zbigniew ‘Ziggy’ M. Szczepiorkowski, MD, PhD, FCAP
Disclosures: Grifols, Inc, - Honorarium and research support; Cerus - Research support; Fresenius Kabi - Scientific Advisory Board

 Ziyan Zhu, MD, PhD
No relationship to disclose

James M. Szymanski, MD, MHA
No relationship to disclose

Jessica Constanzo-Yanez, BSc 
No relationship to disclose

Philip Berardi, MD, PhD, FRCPC
Disclosures: Novartis Canada, Inc - Honorarium; Janssen, Inc - Honorarium; Seattle Genetics, Inc - Honorarium

Glenn E. Ramsey, MD
Disclosures: Immucor - Honorarium; AstrZeneca (spouse) - Honorarium; Exagen Diagnostics (spouse) - Honorarium

Lihui Yin, PhD
No relationship to disclose

Willy A. Flegel, MD

Chelsea A. Sheppard, MD
Disclosure: Grifols SA, Consultant fee

Dimitri S. Monos, PhD
No relationship to disclose

Moderators

Willy A. Flegel, MD 

Swee Lay Thein, MD, PhD
No relationship to disclose

S. Gerald Sandler, MD
No relationship to disclose 

Gregory A. Denomme, PhD, FCSMLS(D) 

 

Learning Objectives
1. Discuss how advances in molecular immunohematology are changing patient care.
2. Discuss patient care strategies from examples (vignettes) described during case reviews.
3. Review the fundamentals of the molecular basis for blood group antigen expression.
4. Identify red cell genotyping strategies to prevent alloimmunization
5. Discuss the future of red cell genotyping in personalized transfusion medicine and its role in
improving patient safety.

ACCME Accreditation Statement:
BloodCenter of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement:
BloodCenter of Wisconsin designates this Live Activity for a maximum of 6 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals
BloodCenter of Wisconsin designates this activity for up to 6 hours of participation for continuing education for allied health professionals.

BloodCenter of Wisconsin is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

 

Registration Fee: $95.00 US

If you wish to register by check, please complete the manual registration form and mail with a check to the address on the form.

This is the enrollment area for NIH and FDA employees only. This requires a code for enrollment. Please contact Karen Byrne -  kbyrne@cc.nih.gov   to access the enrollment code